Insider buying
~$1.2K1,000 sh @ $1.16
Traded Sep 22, 2025 · filed 220 days later
The CFO of Estrella Immunopharma paid $1.2K out of pocket for Estrella Immunopharma shares. Shares held went up 6% with this purchase.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Oct 7, 2025 · Filed Apr 30, 2026
The CFO of Estrella Immunopharma paid $1.3K out of pocket for Estrella Immunopharma shares.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$1,330
Shares × reported transaction price
<$25K
+0.4%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 1 month
Confirmed open-market purchases by the same insider in the available history
No
Compared with 2 earlier confirmed purchases
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
Closed at $1.26 on Oct 7, 2025, 74% above its 52-week low and 15% below its high, after a 30% rise over the previous 30 trading days
52-week range $0.726 (Nov 1, 2024) to $1.49 (Feb 20, 2025), 70% of the way up, from 249 adjusted closes. 30 trading days earlier: $0.969 on Aug 25, 2025. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −22.6% | +1.8% | −24.4% |
| 30 days | −31.7% | +5.5% | −37.3% |
| 90 days | −52.5% | +1.5% | −54.0% |
| 180 days | −43.1% | +7.1% | −50.3% |
Past results only. Not a forecast.
Insider buying
Traded Sep 22, 2025 · filed 220 days later
The CFO of Estrella Immunopharma paid $1.2K out of pocket for Estrella Immunopharma shares. Shares held went up 6% with this purchase.
Insider buying
11 days before an 8-KTraded Sep 11, 2025 · filed 231 days later
The CFO of Estrella Immunopharma paid $104 out of pocket for Estrella Immunopharma shares.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.